Clinical Trial Update: QUILT-3.088: NANT Pancreatic Cancer Vaccine [Phase 2]

View source ↗

Summary

A Phase 2 trial of the NANT Pancreatic Cancer Vaccine (QUILT-3.088) for metastatic pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• NANT Pancreatic Cancer Vaccine

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: WITHDRAWN